We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The Union-Tribune reports that, after public input, our transit planners have hit the reset button on their ruinous and wasteful $4 billion train tunnel folly. But, sadly, their idea of reset is ...

In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Globus Medical (GMED – Research Report), with a ...

"Smiths Medical issues urgent medical device correction for certain Portex intubation tubes due to manufacturer defect, posing serious risk of inadequate ventil ...

Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...

Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...

DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

Nearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...